Inappropriate change in quantitative human chorionic gonadotropin (hCG) in early pregnancy. O02.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Procedure Code: 84702 Human Chorionic GonadotropinCMS Policy Number: 190.27 Back to NCD List Description: Human Chorionic Gonadotropin (hCG) is useful for monitoring and diagnosis of germ cell neoplasms of the ovary, testis, mediastinum, retroperitoneum, and central nervous system. In addition, hCG is useful for monitoring pregnant
Diagnosis Index entries containing back-references to O02.81: Inappropriate change in quantitative human chorionic gonadotropin O02.81 (hCG) level of quantitative human chorionic gonadotropin O02.81 (hCG) Pregnancy (single) (uterine) - see also Delivery and Puerperal biochemical O02.81. chemical O02.81
O02.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Inapprop chg quantitav hCG in early pregnancy.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.
Z09ICD-10 code Z09 for Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Inappropriate change in quantitative human chorionic gonadotropin (hCG) in early pregnancy. O02. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM O02.
LOINC MapOrder CodeOrder Code NameResult Code004416hCG,Beta Subunit, Qnt004417
Other specified counselingICD-10 code Z71. 89 for Other specified counseling is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | ICD-10-CM.
If the doctor's documentation had just documented, “positive pregnancy test,” the code would be Z32. 01, Encounter for pregnancy test, result positive.
ICD-9 Code Transition: 780.79 Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
Code Z33. 1 This code is a secondary code only for use when the pregnancy is in no way complicating the reason for visit. Otherwise, a code from the obstetric chapter is required.
A positive beta human chorionic gonadotropin (hCG) level usually means that you are pregnant. Pregnancy tests detect the hCG hormone in the blood and urine. The beta hCG levels are also measured using a test known as quantitative hCG testing.
Do the test on your first urination of the morning. The test may be more accurate at this time, because morning urine usually has more HCG. Hold the dipstick in your urine stream for 5 to 10 seconds. For kits that include a collection cup, urinate into the cup, and insert the dipstick into the cup for 5 to 10 seconds.
The Beta HCG-Blood Test is done to know whether an individual is having normal or abnormal HCG levels in the blood of the body. The doctor may ask to perform this test to confirm the pregnancy, to determine the appropriate age of the fetus, diagnose a potential miscarriage (spontaneous loss of pregnancy) of the baby.
84702. Human Chorionic Gonadotropin. hCG. Coverage Indications, Limitations, and/or Medical Necessity. Human Chorionic Gonadotropin (hCG) is useful for monitoring and diagnosis of germ cell neoplasms of the ovary, testis, mediastinum, retroperitoneum, and central nervous system.
There are no CMS National Coverage Determinations for human chorionic gonadotropin (hCG). AHFS Drug Information 2019 Edition does not support any off-label uses of human chorionic gonadotropin (hCG) and recommends against the off-label use of hCG for the treatment of obesity.
Although the most common cause of an elevated HCG level in females is pregnancy, occasionally, a HCG-secreting tumor is suspected and other conditions such as gestational trophoblastic disease (GTD), nontrophoblastic neoplasms, or a pituitary source of HCG, must be considered.
Many different kinds of tumors produce hCG, especially the free β-subunit type of hCG. High levels of β-hCG may indicate a particularly aggressive form of cancer.
Similarly to LH, FSH, and TSH, human chorionic gonadotropin (hCG) is a member of the glycoprotein family and consists of two subunits (α and β chains) that are associated to the intact hormone. 1-7 The α-chains in all four of these glycoprotein hormones are virtually identical, whereas the β-chains have greatly differing structures and are responsible for the respective specific hormonal functions.
1 This assay is intended for the early detection of pregnancy.
If serial monitoring is required, please use the serial monitoring number 480038 to order. This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R).
hCG is produced in the placenta during pregnancy. In nonpregnant women, it can also be produced by tumors of the trophoblast, germ cell tumors with trophoblastic components, and some nontrophoblastic tumors.
It also influences steroid production. The serum of pregnant women contains mainly intact hCG. Measurement of the hCG concentration permits the diagnosis of pregnancy just one week after conception. The determination of hCG in the first trimester of pregnancy is of particular importance.
Values obtained with different assay methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy. This procedure does not provide serial monitoring; it is intended for one-time use only. If serial monitoring is required, please use ...
Elevated hCG concentrations not associated with pregnancy are found in patients with other diseases, such as tumors of the germ cells, ovaries, bladder, pancreas, stomach, lungs, and liver. 6,7
Blood typing is a screening test to determine blood groups and Rh antigen for blood transfusion and pregnancy. The four blood groups A, B, O, and AB are determined by the presence of antigens A and B or their absence (O) on a patient's red blood cells. In addition to ABO grouping, most immunohematology testing includes evaluation of Rh typing tests for Rh (D) antigen. Blood cells that express Rh (D) antigen are Rh positive. Red blood cells found lacking Rh (D) are considered Rh negative. Rh typing is also important during pregnancy because of the potential for mother and fetus Rh incompatiblity. If the mother is Rh negative but the father is Rh positive, the fetus may be positive for the Rh antigen. As a result, the mother’s body could develop antibodies against the Rh antigen. These antibodies may cross the placenta and cause destruction of the baby’s red blood cells, resulting in a condition known as hemolytic disease of the fetus and newborn.
Our LDS system scores over 10,000 test-disease/condition pairs, assigns a rank from 1 to 10 and displays the ranks as a simple color coded indicator of clinical relevance, medical necessity and testing indication.
In normal pregnancy, hCG can be detected in both urine and serum as early as 7 to 10 days after conception.
Reflex bHCG, Quantitative if positive. This volume may not allow for repeat testing. Allow specimen to completely clot (this can take up to 60 minutes). Centrifuge for 15 minutes as soon as the specimen is clotted.
The ICD-10-CM code set replaced the ICD-9-CM code set on October 1, 2015, for covered entities under the Health Insurance Portability and Accountability Act (HIPAA). ICD-10-CM uses different formatting and an expanded character set.
The following ICD-10 resources (included below as PDFs) were developed by Labcorp:
Appointments must be made at least two hours in advance. Walk-ins are also welcome. Please note: not all lab locations offer all services
Labcorp continues to rely on the ordering physician to provide diagnostic information for the individual patient. In accordance with HIPAA standards, Labcorp requires a valid diagnosis at the highest level of specificity in order to bill third-party payers, including Medicare and Medicaid. Missing diagnoses, diagnosis codes lacking the highest level of specificity, and nonspecific narratives all require follow-up with the ordering physician or his/her authorized designee for clarification. Providing a formatted ICD-10-CM code at the time of order will minimize letters and/or calls.